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Effect of urinary pH and diatrizoate on Bence Jones protein
nephrotoxicity in the rat. Both low urinary pH and radiocontrast agents
may intensify myeloma nephrotoxicity. To study the effects of these
factors, we determined inulin clearances (C1,,) before and after infusions
of human Bence Jones protein (BJP) in male Sprague-Dawley rats in a
dose previously shown to be nephrotoxic. Rats that drank 0.15 M
NaHCO3 for 48 hr before study had no change in C1,, (+ 3 20%) after
BJP unlike those that drank 0.15 M NH4C1 (—33 14%, P < 0.05);
urinary pH differed (7.6 0.1 vs. 6.2 0.1, P <0.05), but urinary flow
rates did not. The acidifying regimen was used in all subsequent groups.
Infusion of diatrizoate (DTZ) after BJP produced a further decrease in
C1, (—85 8%, P < 0.05). In contrast, infusion of albumin, which
raised plasma protein concentration to that seen in BJP-infused rats, did
not change C1,, (+ 39 17%). Infusion of beta-lactoglobulin also led to
a greater decrease in C1,, after DTZ(—35 9 vs. —67 8%, P <0.05),
but myoglobin did not (—58 7 vs. —54 12%). Urinary pH and flow
rate did not differ between any DTZ-infused group and its appropriate
control. These data suggest that aciduria independent of urinary flow
rate increases the nephrotoxicity of BJP. In this setting, DTZ further
intensifies the nephrotoxicity of BJP as well as some but not all
filterable proteins.
Effet du pH urinaire et du diatrizoate sur Ia néphrotoxicité de Ia
protéine de Bence Jones chez le rat. Un pH urinaire bas et les produits de
contraste peuvent accroitre la néphrotoxitë du myélome. Pour étudier
les effets de ces facteurs, nous avons déterminé les clearances de
l'inuline (C1,,) avant et après perfusion de protéine de Bence Jones
humaine (BJP) chez des rats males Sprague-Dawley a dose
préalablement montrée nephrotoxique. Les rats qui buvaient 0,15 M
NaHCO3 pendant 48 hr avant l'étude n'avaient pas de modification de
C1, (+3 20%) apres BJP ala difference de ceux qui buvaient 0,15 M
NH4C1 (—33 14%, P 0,05); les pH urinaires différaient (7,6 0,1
contre 6,2 0,1, P 0,05), mais non les debits urinaires. Le régime
acidifiant a etC utilisC chez tous les groupes ultérieurs. La perfusion de
diatrizoate (DTZ) aprhs BJP a entrainC une diminution supplémentaire
de C1,, (—85 8%, P  0,05). A l'opposé une perfusion d'albumine, qui
augmentait Ia protidémie a Ia valeur observCe chez les rats perfusCs
avec BJP ne modifiait pas C1,, (+39 17%). Une perfusion de
bCta-lactoglobuline a Cgalement entrainé une plus forte baisse de C1,,
après DTZ (—35 9 contre —67 8%, P  0,05), mais non de Ia
myoglobine (—58 7 contre —54 12%). Le pH et le debit urinaires
ne différaient pas entre audun des groupes perfusCs par le DTZ et leur
contrôle approprié. Ces données suggérent que l'acidurie,
independamnient du debit urinaire, augmente Ia néphrotoxicitC de la
BJP. Dans ce schema, DTZ accentue encore Ia néphrotoxicité de la
BJP, de méme que certaines, mais non toutes les protéines filtrables.
Bence Jones protein (BJP) is present in the urine in about
50% of patients with multiple myeloma [1, 2] and in greater than
90% of patients with myeloma and acute renal failure (ARF) [3].
Accordingly, urinary BJP has been implicated as the principal
factor predisposing toward myeloma-associated ARF. Several
factors including urinary pH, urinary flow rate, radiocontrast
agents, and hypercalcemia have been considered to influence
the nephrotoxicity of BJP.
On the basis of the observation that BJP precipitates maxi-
mally in vitro at a pH of 4.8 to 6.0 [4], many clinicians
recommend alkalinization of the urine for the therapy of ARF
due to BJP. However, this concept has not been tested in a
controlled manner. Clyne, Pesce, and Thompson [51 found a
salutory effect of sodium bicarbonate on serum creatinine and
urea concentrations in the rat but did not report urinary flow
rates; a high flow rate is also thought to decrease the toxicity of
BJP [6, 71. Smolens, Venkatachalam, and Stein [81 used urine
acidification to maximize the intensity of BJP nephrotoxicity in
the LOU/M rats. Falconer Smith et al [9] have shown that
acidification of the urine increases the excretion rate of human
light chain in the isolated rat kidney and patients with myeloma.
Thus, our first objective was to determine whether alkaliniza-
tion of the urine, independent of urinary flow rate, protected
against BJP-induced nephrotoxicity in a rat model which we
have previously described [10].
Radiocontrast agents have been associated with ARF in
multiple myeloma for several years. Despite the initial reports
of ARF following intravenous pyelography [11—141, several
groups of investigators argue that the risk of such a toxic effect
is quite low [15, 16]. Nevertheless, others conclude that radio-
contrast drugs should be avoided in patients with myeloma [171.
This recommendation is buttressed by more recent studies that
show that radiocontrast agents may cause ARF unassociated
with myeloma, particularly in the elderly diabetic patient with
pre-existent renal insufficiency [18—201. However, these radio-
contrast agents have not been studied in animal models of
myeloma-associated renal failure. Thus, the second objective of
these studies was to determine whether a specific radiocontrast
agent, diatrizoate meglumine (DTZ), influences the degree of
renal failure in our rat model of acute BJP nephrotoxicity.
Methods
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All studies were carried out in male Sprague-Dawley rats
(Charles River Breeding Labs, Cambridge, Massachusetts,
USA) that weighed between 90 and 200 g. Smaller rats were
Table 1. Summary of protocols for the various groups
Urinary pH and diatrizoate on BJP toxicity 47
Group Drink Test infusion Diatrizoate
l-BJP NaHCO1 Bence Jones protein (—)
2-BJP NH4CI Bence Jones protein (—)
3-BJPID NH4CI Bence Jones protein (+)
4-CON/D NH4CI Vehicle only (+)
5-BSAID NH4CI Bovine albumin (+)
6-BLG NH4C1 /3-lactoglobulin (—)
7-BLG/D NH4C1 /3-lactoglobulin (+)
8-MYG NH4C1 Myoglobin (—)
9-MYG/D NH4C1 Myoglobin (+)
used because of the limited availability of BJP. All rats had free
access to a low sodium chloride chow (ICN Pharmaceuticals,
Cleveland, Ohio, USA) and tap water until 48 hr before the
clearance study. Thereafter, all rats drank either 0.15 M NH4CI
or 0.15 M NaHCO3 in 5% dextrose ad libitum until the time of
clearance study. Animals were anesthetized with mactin
(Promonta, Hamburg, West Germany) 100 mg/kg body wt i.p.
After tracheostomy, the rats were placed on heated boards.
Rectal temperature was maintained at 37°C with a thermostat.
A suprapubic incision was made and a PE-50 bladder catheter
was placed. The initial urine collection for pH was obtained
under water-equilibrated mineral oil in pre-weighed vials. A
PE-50 catheter was inserted into the jugular vein and 2 to 4%
inulin in Ringer's bicarbonate was infused at 1 ml/l00 g body
wt/hr. A PE-50 catheter was inserted into the femoral artery for
monitoring blood pressure (BP) throughout the study and for
periodic sampling of blood.
Clearance of inulin (C1) was determined before and after the
infusion of test solutions in each group. After surgical prepara-
tion and at least 30 mm for equilibration, the 30-mm control
period was begun. Plasma samples were obtained at the begin-
ning and end of the period for determination of inulin and
protein concentrations and hematocrit; urine samples were
collected throughout for volume and inulin concentration. All
test proteins were infused in 6 ml of 0.15 M Ringer's bicarbonate
over 2 hr. Because preliminary studies showed that 500 mg/100
g body wt of beta-lactoglobulin (BLG) produced renal failure as
in our previous study [10], this concentration was used for all
infused proteins. Upon completion of the test infusion, certain
groups were then infused with 60% DTZ (Winthrop Labs., New
York, New York, USA) 0.8 ml/100 g body wt over 5 mm. This
dose was selected because previous studies in this laboratory
have shown that it produces a reduction in C1 in euvolemic rats
for at least 60 mm [21]. After 60 mm for equilibration, a second
C1 was obtained as above. Plasma osmolality was also deter-
mined at this time.
Nine groups of rats were studied (Table 1). Groups l-BJP (N
= 7) and 2-BJP (N = 9) drank 0.15 M NaHCO3 or 0.15 M
NH4C1, respectively, before BJP infusion. Because the am-
monium chloride drink was associated with a decrease in C1,,, it
was used in all subsequent groups. Group 3-BJP/D (N = 5)
received both BJP and DTZ. Control group 4-CON/D (N = 7)
was infused with the vehicle and DTZ only. In control group
5-BSA/D (N = 6), bovine serum albumin (BSA) followed by
DTZ was infused as a nonfilterable protein in amounts sufficient
to increase plasma protein concentration to that observed in
BJP-infused rats and this group thereby provided a control for
Fig. 1. SDS-PAGE electrophoretic patterns of the original BJP, the
infusate, and selected urine samples after BJP infusion. The standards
indicated in the uppermost band are lysozyme, lactoglobulin,
trypsinogen, egg albumin, and bovine albumin in ascending order of
molecular weights (daltons).
the oncotic effect of hyperproteinemia. As in our previous study
[10], BLG with a molecular weight of about 35,000 daltons and
an isoelectric point (p1) ranging between 4.7 to 5.3 and
myoglobin (MYG) with a molecular weight of 17,000 daltons
and a p1 of 6.9 were infused with or without DTZ in groups
6-BLG (N = 5) and 7-BLG/D (N = 6) and groups 8-MYG (N =
4) and 9-MYG/D (N = 6), respectively, to test for the specificity
of the effect of DTZ on the nephrotoxicity of filterable proteins.
In randomly selected animals, protein electrophoresis was
performed on the infusate and on the urine collected after BJP
infusion to establish the distribution of molecular forms of BJP
in these fluids. The BJP used in this study was that used in the
series 1 experiments which we have previously reported [10].
This protein was obtained from a patient with ARF and multiple
myeloma and is a kappa BJP with a mixture of monomers,
dimers, and higher molecular weight aggregates (Fig. 1). The
protein electrophoretic patterns of the original protein, the
infusate, and the urine samples recovered from a representative
group of BJP-infused rats were similar.
Analytical methods, calculations, and statistics
Inulin concentration was determined as previously described
[10]. Osmolality was determined by vapor pressure osmometry
(Wescor, Logan, Utah, USA). Hematocrit was estimated with
the IEC MB centrifuge (International Equipment Co.,
Needham Heights, Massachusetts, USA). Urinary pH was
determined with a BMS3 Mk2 blood gas analyzer (Radiometer,
Copenhagen, Denmark). Plasma protein concentration was
determined by refractometry (American Optical Co., Buffalo,
New York, USA). Protein electrophoresis was carried out on
SDS-polyacrylamide gel (SDS-PAGE) [22].
Clearance of inulin was calculated according to the formula:
U1,, x VIP1,. = C1,, (1)
The change in C1 is expressed as fractional change factored
by body weight. Rats that had an initial C1 of less than 600
pilmin/lOO g body wt were not considered adequate for study.
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Table 2. Systemic variables
BPa Plasma proteina Plasma
osmolality
Change in
plasmaBody wt Pre Post Pre Post
Group g mm Hg mg/mi mOsm/kg volume %
1-BJP 120 5 128 5 118 3 58 1 62 2 309 6 +53 5
2-BJP 118 7 126 4 126 3 54 3 54 2 298 4 +42 4
P 1 vs. 2 NS NS NS NS <0.05 NS NS
3-BJP/D 122 2 118 7 112 5 55 3 72 2 322 10 +40 9
P 2 vs. 3 NS NS <0.05 NS <0.01 NS NS
4-CON/D 135 10 109 6 90 4 55 4 46 2 309 3 +58 6
5-BSA/D 110 6 122 8 115 4 52 2 71 3 323 6 +104 26
6-BLG 119 9 125 9 114 7 54 2 43 2 324 8 +57 10
7-BLG/D 129 6 124 6 128 5 56 2 52 3 319 4 +32 10
P6 vs. 7 NS NS NS NS <0.05 NS NS
8-MYG 113 8 116 10 106 2 48 4 46 4 307 2 +39 8
9-MYG/D 122 6 119 5 112 6 53 4 49 2 314 4 +26 5
P8vs.9 NS NS NS NS NS NS NS
Pre and Post values refer to clearance periods before and after test infusions.
Table 3. Urine pH and flow rate and inulin clearance
Urine flow ratea
Urine pH Pre Post Pre
Inulin clearanc&
Post Change
Group units 1td/min pJ/min/100 g body wt %
1-BJP 7.57 0.09 2.9 0.3 8.6 2.1 1449 210 1337 202 +3 20
2-BJP 6.24 0.11 3.5 0.3 6.0 2.0 1314 235 652 144 —33 14
P 1 vs. 2 <0.01 NS NS NS <0.05 <0.05
3-BJP/D 6.12 0.36 5.1 0.9 11.8 3.5 1320 297 245 147 —85 8
P 2 vs. 3 NS NS <0.05 NS <0.05 <0.05
4-CON/D 5.83 0.04 9.8 2.8 29.2 4.4 941 108 1089 99 +24 13
5-BSA/D 6.13 0.11 3.0 0.7 7.8 2.9 929 129 1459 313 +39 17
6-BLG 6.19 0.13 6.5 2.0 6.0 1.5 1057 159 656 82 —35 9
7-BLG/D 6.20 0.31 4.5 0.8 10.2 1.0 1538 266 452 82 —67 8
P 6 vs. 7 NS NS <0.05 NS NS <0.05
8-MYG 5.72 0.12 6.2 1.7 17.3 4.0 867 94 351 44 —58 8
9-MYG/D 6.10 0.18 4.9 1.0 11.4 1.4 1082 160 444 84 —54 13
P8vs.9 NS NS NS NS NS NS
a Pre and Post values refer to clearance periods before and after test infusions.
The fractional change in plasma volume was estimated from
serial hematocrit as previously described [231.
Results are expressed as mean SEM. Differences between
groups were determined by the unpaired Student's t test and
within groups by the paired test. Differences between groups
for fractional change in C1/100 g body wt were determined by
the Wilcoxon rank sum test for nonparametric data. Differences
among groups were determined by the analysis of variance.
Significance was set at less than 0.05 level.
Results
Mean arterial BP and final plasma osmolalities before and
after the test infusions did not differ among the groups (Table 2).
The BP after BJP infusion was lower in group 3-BJPID than that
in group 2-BJP, however, there was no significant change in BP
within group 3-BJP/D. The lower arterial BP in group 4-CONID
did not adversely affect C which was well maintained through-
out the study. Final plasma protein concentrations were higher
in groups l-BJP, 3-BJP/D, and 7-BLG/D than in the appropriate
control. The higher final plasma protein concentrations in
groups 3-BJPID and 7-BLG/D probably relate to a decrease in
the excretion of test protein secondary to the marked decrease
in C1, although the difference in final plasma protein in groups
l-BJP and 2-BJP cannot be similarly explained.
In groups l-BJP and 2-BJP, urinary pH differed (P < 0.05),
butthe initial urinary flow rates did not (P = NS) (Table 3). The
decrease in C1, was significant (P < 0.05) in the NH4C1-drinking
rats, but there was no change in C1 in the NaHCO3-drinking
rats (Fig. 2 and Table 3) despite significant volume expansion in
both groups. After BJP infusion in these groups, urinary pH
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Fig. 2. Change in inulin clearance (open bars) and in plasma volume
(solid bars) for all groups.
(6.04 0.30 vs. 5.49 0.11; P = NS) and urinary flow rates
did not differ (P = NS).
In the groups infused with DTZ and their appropriate controls
(groups 2 to 9), the acid urinary pH did not differ (Table 3).
Urinary flow rates did not differ before the infusion of the test
solution in any group as compared to the appropriate control,
but, after test infusions, the urinary flow rates were higher in
groups 3-BJP/D and 7-BLG/D. Despite the infusion of DTZ, C1.
did not decrease in groups 4-CON/D and 5-B SA/D (Table 3 and
Fig. 2). In contrast, C1 decreased (P < 0.01) in group 3-BJP/D
despite volume expansion and a plasma protein concentration
(7.1 g/dl) similar to that for group 5-BSAID (7.2 gIdl). In like
fashion, DTZ was associated with a further decrease in C111 (P <
0.05) in the BLG-infused groups (Fig. 2). However, this effect
of DTZ was not nonspecific. C1 was decreased in aciduric rats
infused with MYG alone (group 8-MYG) but did not decrease
further (P = NS) with the infusion of DTZ (group 9-MYG/D).
Discussion
Our data show that infusion of a human BJP at the selected
dose can produce ARF in aciduric but not alkaluric rats
independently of urinary flow rate. In addition, the administra-
tion of 60% diatrizoate meglumine can intensify the acute renal
insufficiency in rats infused with a human BJP or BLG but not
MYG. Significant plasma volume expansion (P < 0.05), which
would only serve to increase GFR, was produced in all groups.
Our findings of a specific protective effect of urinary
alkalinization on BJP-induced renal failure conforms to previ-
ous observations. These studies, however, had been uncon-
trolled for urinary flow rate which itself may be additive. As
propounded by Pesce et al [24], the mechanism by which
alkalinization of the urine favorably effects C1 may relate to the
interaction between BJP and Tamm-Horsfall protein (THP), a
normal constituent of mammalian urine with a p1 of 3.5.
According to their hypothesis, BJPs with pls ranging between
4.6 and 6.7 will be more cationic in acidic urine and would tend
to aggregate more readily with THP which, by itself, tends to
aggregate in the presence of decreasing pH or increasing
concentration of THP or electrolyte [25]. p1 was not a factor in
our studies since only a single BJP was used; nevertheless, the
effect of urinary alkalinization may be greater or lesser depend-
ing on the p1 of the BJPs.
Monomers of BJP but not dimers or larger aggregates readily
cross the glomerular basement membrane. The electrophoretic
patterns of the original BJP, the BJP in the infusate and in the
urine recovered after BJP infusion are, by inspection, similar in
relative proportions and show monomers, dimers, and larger
molecular weight aggregates. One explanation for this observa-
tion is that the relative proportions of these moieties are
re-established in the urine because of unknown factors—per-
haps unique physicochemical properties. An alternative expla-
nation that all of the moieties cross the glomerular basement
membrane in the same relative proportions seems less likely.
Although the question of which moiety or characteristic of BJP
is most likely to promote nephrotoxicity is important, the
limited availability of this or other BJP precluded such studies.
However, these uncertainties do not adversely effect our con-
clusion that the nephrotoxicity of at least some BJPs is en-
hanced by aciduria and DTZ.
The dose of DTZ that was used in this study is greater than
that used for routine urography in humans but, in our experi-
ence [21], it is needed to produce mild ARF in euvolemic rats.
However, even this large dose did not decrease GFR in group
4-CON/D control rats which underwent plasma volume expan-
sion with Ringers-bicarbonate. This emphasizes the role of the
degree of hydration as an important factor predisposing to
radiocontrast-induced ARF. Clearly, volume expansion was
present in all groups (Fig. 2), yet DTZ enhanced renal failure
with BJP or BLG. Finally, the plasma concentration of DTZ as
estimated by the final plasma osmolalities was not different
among the groups and thus does not explain the differences in
GFR among the groups. We conclude, therefore, that a syner-
gistic effect of DTZ to decrease GFR was clearly present in the
rats infused with BJP or BLG.
The mechanism of nephrotoxicity cannot be discerned from
these studies; micropuncture studies coupled with im-
munohistology may aid in elucidation. Obstruction by cast
formation could be intensified by DTZ and GFR decreased by
an increase in intratubular pressure—another postulated mech-
anism by which these agents produce renal failure. In this
instance, a decrease and not the observed increase in urinary
flow rate might have been expected. Although other radio-
contrast agents may precipitate with BJP in vitro, such an effect
has not been shown for DTZ [12]. Furthermore, an interaction
between THP and DTZ, which has been suggested to occur
with or without BJP [26], seems an unlikely explanation since
there was no effect of DTZ in group 4-CON/D. Another
suggestion by Reed, Williams, and Luke [21] is that the osmotic
effect of DTZ may reduce GFR by tubuloglomerular feedback
[27]. We have no data that bear on this possibility.
Clinical trials will be required to validate our findings in
humans. However, to the extent that these findings are relevant
to human multiple myeloma, our data suggest that the clinical
practice of alkalinization of urine to ameliorate ARF in multiple
myeloma associated with urinary BJP may be efficacious and
that the administration of radiocontrast agents may induce or
worsen renal failure in these patients.
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